The company said that its main focus will be to target the patients needing supplemental medical nutrition for cancer, diabetes and obesity.
Paul Lisenby, CEO of XTend Medical, said: “XTend is seeing an increased presence in the telehealth market and we continue to generate many inquiries from companies looking to implement our remote patient monitoring system into their managed care business.”